Bevacizumab Arrests Osteoarthritis Progression in a Rabbit Model: A Dose-Escalation Study
Cartilage neoangiogenesis holds a prominent role in osteoarthritis (OA) pathogenesis. This study aimed to assess the efficacy bevacizumab, an antibody against vascular endothelial growth factor and inhibitor of angiogenesis, in a rabbit OA model. Animals were divided into four groups: one receiving...
Main Authors: | Gianluca Vadalà, Luca Ambrosio, Caterina Cattani, Roberta Bernardini, Antonino Giacalone, Rocco Papalia, Vincenzo Denaro |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-06-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/10/13/2825 |
Similar Items
-
The Effect of Intravitreal Bevacizumab on Apoptosis of Rat Retina Cells
by: Özcan Kayıkçıoğlu, et al.
Published: (2013-01-01) -
Use of Bevacizumab in the Treatment of Corneal Neovascularization
by: Tuba Çelik, et al.
Published: (2015-01-01) -
The Potential Influence of Residual or Recurrent Disease on Bevacizumab Treatment Efficacy in Ovarian Cancer: Current Evidence and Future Perspectives
by: Klaudia Żak, et al.
Published: (2024-03-01) -
Short-term intraocular pressure changes after intravitreal bevacizumab injection
by: Ali Dehghani, et al.
Published: (2014-08-01) -
Bevacizumab suppressed degenerative changes in articular cartilage explants from patients with osteoarthritis of the knee
by: Masaichi Sotozawa, et al.
Published: (2023-01-01)